Did Utah Medical Products, Inc. (NASDAQ:UTMD) Insiders Sell Shares?

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Utah Medical Products, Inc. (NASDAQ:UTMD).

What Is Insider Buying?

Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock in the company. However, most countries require that the company discloses such transactions to the market.

We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Columbia University study found that ‘insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers’.

Check out our latest analysis for Utah Medical Products

The Last 12 Months Of Insider Transactions At Utah Medical Products

Over the last year, we can see that the biggest insider sale was by the Director, Barbara Payne, for US$226k worth of shares, at about US$92.29 per share. That means that an insider was selling shares at slightly below the current price (US$98.32). When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. However, while insider selling is sometimes discouraging, it’s only a weak signal. It is worth noting that this sale was only 10.3% of Barbara Payne’s holding. Barbara Payne was the only individual insider to sell shares in the last twelve months.

Barbara Payne sold a total of 5094 shares over the year at an average price of US$90.65. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqGS:UTMD Recent Insider Trading, September 1st 2019
NasdaqGS:UTMD Recent Insider Trading, September 1st 2019

Insider Ownership of Utah Medical Products

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 7.3% of Utah Medical Products shares, worth about US$27m. While this is a strong but not outstanding level of insider ownership, it’s enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Utah Medical Products Insiders?

The fact that there have been no Utah Medical Products insider transactions recently certainly doesn’t bother us. We don’t take much encouragement from the transactions by Utah Medical Products insiders. The modest level of insider ownership is, at least, some comfort. I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow for free .

Of course Utah Medical Products may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.